3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance in India. The company offers qPCR-based and lateral flow assays rapid tests and Next Gen Sequencing -based molecular diagnostic kits for accurate and reliable testing on patient samples under the TRUPCR, TRUNGS, TRURAPID, brand for testing on patient samples to diagnostics labs. It also offers agrochemical products; technical support and training services. 3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.
| Current Price | ₹1,115.90 |
|---|---|
| Market Cap | ₹956 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Fertilizers and Agricultural Chemicals > 0 |
| P/E Ratio | 16 |
| Return on Equity | 19.89% |
| Beta (1Y) | 0.64 |
| Dividend Yield | 0.45% |
1. Agrochemicals-7.6% 2. Diagnostic Kits-92.4%
Kilpest India Ltd. is trading at ₹1,115.90, with a market capitalisation of ₹956 Cr.
Kilpest India Ltd. operates in the Materials > Materials > Chemicals space (Fertilizers and Agricultural Chemicals > 0).
Kilpest India Ltd. has a P/E of 16 and a return on equity of 19.89%.